| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/22/2011 | EP2335736A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2334693A1 Methods of long-term culture of eukaryotic cells and uses thereof |
| 06/22/2011 | EP2095825B1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 06/22/2011 | EP1207876B1 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing |
| 06/22/2011 | DE102009050407A1 Entzündungshemmendes Mittel enthaltend Hydrolysate aus Pflanzenextrakten An anti-inflammatory agent containing hydrolysates from plant extracts |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN1596314B Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN102105488A Methods of long-term culture of eukaryotic cells and uses thereof |
| 06/22/2011 | CN102105453A Therapeutic agent for chronic renal failure |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105174A Diagnostic agents selective against metalloproteases |
| 06/22/2011 | CN102105167A Prophylactic or therapeutic agent for axial myopia |
| 06/22/2011 | CN102105154A Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 06/22/2011 | CN102101854A Benzomacrolide compounds having pancrelipase inhibiting activity and synthesis method and use thereof |
| 06/22/2011 | CN102101825A PTP1B (Protein Tyrosine Phosphatase 1B) inhibitor, and synthesis and application thereof |
| 06/22/2011 | CN102100895A Technology for preparing novel integrative dosage form of decoction for tonifying middle-Jiao and Qi |
| 06/22/2011 | CN102100804A Snore relieving composite and preparation method thereof |
| 06/22/2011 | CN102100755A Preparation technology of integrated ephedra, aconite and asarum decoction novel dosage form |
| 06/22/2011 | CN102100672A Vascular endothelial growth factor chitosan microsphere and application thereof |
| 06/22/2011 | CN101703634B Medicament for treating cellulitis and preparation method thereof |
| 06/22/2011 | CN101703472B Granulating coated slow release product of cysteamine hydrochloride and preparation method thereof |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101575333B Quinazoline derivatives and medical application thereof |
| 06/22/2011 | CN101475571B Beta-carbolines cell cycle protein related kinase 2 inhibitor and use thereof |
| 06/22/2011 | CN101151032B Pharmaceutical composition and method using antifungal agent in combination |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 06/21/2011 | CA2635412C Agent for prophylaxis and treatment of asthenopia or pseudomyopia |
| 06/21/2011 | CA2523098C Skin collagen production promoter |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2483562C Heterotricyclyl-6-alkylidene-penems as beta-lactamase inhibitors |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2470731C Corticotropin releasing factor 2 receptor agonists |
| 06/21/2011 | CA2435681C Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 06/21/2011 | CA2407556C Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2355347C Pharmaceutical compositions comprising quinapril magnesium |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2303460C Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors |
| 06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/16/2011 | WO2011072082A2 Modulation of hsp47 expression |
| 06/16/2011 | WO2011071692A1 Modulating cellular electrophysiology |
| 06/16/2011 | WO2011071135A1 Oxazine derivative |
| 06/16/2011 | WO2011071134A1 Prophylactic composition for influenza infection |
| 06/16/2011 | WO2011071109A1 Fused heterocyclic compound having amino group |
| 06/16/2011 | WO2011071099A1 Anticancer anti-mortalin peptide antibodies |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011071059A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance |
| 06/16/2011 | WO2011071048A1 Heteroarylcarboxylic acid ester derivative |
| 06/16/2011 | WO2011070970A1 Overexpression inhibitor of thymic stromal lymphopoietin |
| 06/16/2011 | WO2011070781A1 Substituted aminothiazine derivative |
| 06/16/2011 | WO2011069932A1 Novel therapeutic uses for an ornithine alpha-ketoglutarate complex |
| 06/16/2011 | WO2011069921A1 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof |
| 06/16/2011 | WO2011069918A1 Novel medical use |
| 06/16/2011 | WO2011069335A1 Use of pyridines compounds in preparing rna interference reinforcing agent |
| 06/16/2011 | US20110144483 Imaging agents |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144320 N-pyrazole a2a receptor agonists |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144195 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
| 06/16/2011 | US20110144189 Guanylhydrazone compounds, compositions, methods of making and using |
| 06/16/2011 | US20110144179 Substituted Heterocyclic Mercaptosulfonamide Metalloprotease Inhibitors |
| 06/16/2011 | US20110144149 Gemifloxacin process and polymorphs |
| 06/16/2011 | US20110144147 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 06/16/2011 | US20110144137 method for preventing or alleviating the noxious effects resulting from toxicant exposure |
| 06/16/2011 | US20110144135 Compounds for Modulating TRPV3 Function |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142974 Trigonelline as a muscle stimulant |
| 06/16/2011 | US20110142962 Oral Rehydration Solutions Comprising Dextrose |
| 06/16/2011 | US20110142936 Implants and biodegradable fiducial markers |
| 06/16/2011 | US20110142931 Soft tablet containing dextrose monohydrate |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142889 Compositions and methods for oral drug delivery |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142857 Methods of altering peripheral b cell populations and uses thereof |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142852 Multispecific antibodies |
| 06/16/2011 | US20110142820 Novel Targets for Regulation of Angiogenesis |
| 06/16/2011 | US20110142818 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 06/16/2011 | US20110142809 Method for separating highly active stem cells from human stem cells and highly active stem cells separated thereby |
| 06/16/2011 | US20110142794 Methods and Compositions to Determine the Chemosensitizing Dose of Suramin Used in Combination Therapy |
| 06/16/2011 | US20110142790 Polyol Based - Bioceramic Composites |
| 06/16/2011 | US20110142765 Novel phloroglucinol derivatives having selectin ligand activity |
| 06/16/2011 | US20110142762 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 06/16/2011 | US20110142759 Agents and methods for the imaging of myelin basic protein |